Literature DB >> 9933427

Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice.

K Sapru1, P K Stotland, M M Stevenson.   

Abstract

The difference in severity of Pseudomonas aeruginosa-induced chronic lung infection may be determined by differences in host inflammatory responses. In the present study we investigate this possibility using BALB/c and C57Bl/6 mice, resistant and susceptible, respectively, to chronic lung infection with P. aeruginosa. Following intratracheal inoculation of P. aeruginosa-impregnated agar beads, C57Bl/6 mice mounted a stronger inflammatory response with significantly higher total cell numbers in the bronchoalveolar lavage fluid compared with BALB/c mice. While polymorphonuclear leucocytes were the predominant cell in C57Bl/6 mice, macrophages constituted the majority in BALB/c mice at day 7 post-infection. Alveolar macrophages from C57Bl/6 mice showed significantly higher spontaneous production of nitric oxide (NO) at day 7 post-infection compared with BALB/c mice. Following in vitro stimulation with heat-killed Pseudomonas antigen, these cells produced significantly higher NO compared with cells from BALB/c mice at day 21 post-infection. Production of tumour necrosis factor-alpha (TNF-alpha) by alveolar macrophages was significantly higher at day 7 in BALB/c mice compared with C57Bl/6 mice, which showed significantly higher levels at day 28 post-infection. Taken together, these results suggest that defects in the host inflammatory process contribute to the variable outcome of chronic lung infection with P. aeruginosa. An exaggerated inflammatory response dominated by polymorphonuclear cells correlates with susceptibility to infection, whilst a modest inflammatory response dominated by macrophages correlates with resistance. Moreover, the quantity and timing of production of NO and TNF-alpha by alveolar macrophages may modulate the course and outcome of infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933427      PMCID: PMC1905184          DOI: 10.1046/j.1365-2249.1999.00762.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

Review 1.  Immunology of cystic fibrosis.

Authors:  J O Warner
Journal:  Br Med Bull       Date:  1992-10       Impact factor: 4.291

Review 2.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 3.  Macrophages and polymorphonuclear neutrophils in lung defense and injury.

Authors:  Y Sibille; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1990-02

4.  Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections.

Authors:  G B Pier; G J Small; H B Warren
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

5.  Characterization of chronic bronchopulmonary Pseudomonas aeruginosa infection in resistant and susceptible inbred mouse strains.

Authors:  M Tam; G J Snipes; M M Stevenson
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

6.  L-arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon.

Authors:  J Park; Y Rikihisa
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

7.  A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia.

Authors:  J R Starke; M S Edwards; C Langston; C J Baker
Journal:  Pediatr Res       Date:  1987-12       Impact factor: 3.756

8.  Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine.

Authors:  J Y Lin; K Chadee
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

9.  Macrophage activation during Plasmodium chabaudi AS infection in resistant C57BL/6 and susceptible A/J mice.

Authors:  M M Stevenson; D Y Huang; J E Podoba; M E Nowotarski
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis.

Authors:  G Santis; L Osborne; R A Knight; M E Hodson
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

View more
  17 in total

1.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  The role of CD1d-restricted NKT cells in the clearance of Pseudomonas aeruginosa from the lung is dependent on the host genetic background.

Authors:  Patrick Benoit; Vaia Yioula Sigounas; Jenna L Thompson; Nico van Rooijen; Matthew E Poynter; Matthew J Wargo; Jonathan E Boyson
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

3.  Modulation of immune response by interleukin-10 in systemic Corynebacterium kutscheri infection in mice.

Authors:  Eui-Suk Jeong; Kyoung-Sun Lee; Seung-Ho Heo; Jin-Hee Seo; Yang-Kyu Choi
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

4.  Mucus secretion by single tracheal submucosal glands from normal and cystic fibrosis transmembrane conductance regulator knockout mice.

Authors:  Juan P Ianowski; Jae Young Choi; Jeffrey J Wine; John W Hanrahan
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

5.  Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.

Authors:  Claudine Guilbault; Peter Stotland; Claude Lachance; Mifong Tam; Anna Keller; Luann Thompson-Snipes; Elizabeth Cowley; Thomas A Hamilton; David H Eidelman; Mary M Stevenson; Danuta Radzioch
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

6.  Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection.

Authors:  Alison R Kerr; June J Irvine; Jennifer J Search; Neill A Gingles; Aras Kadioglu; Peter W Andrew; William L McPheat; Charles G Booth; Tim J Mitchell
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Host and bacterial factors involved in the innate ability of mouse macrophages to eliminate internalized unopsonized Escherichia coli.

Authors:  T S Hamrick; E A Havell; J R Horton; P E Orndorff
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

8.  Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis.

Authors:  Robert Nason; Jae Y Jung; Richard A Chole
Journal:  J Assoc Res Otolaryngol       Date:  2009-01-15

9.  Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  Adam J Ritchie; Andrew O W Yam; Kara M Tanabe; Scott A Rice; Margaret A Cooley
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.

Authors:  Dalia Haydar; Rene Gonzalez; Beth A Garvy; Sylvie Garneau-Tsodikova; Nishad Thamban Chandrika; Therese J Bocklage; David J Feola
Journal:  Immunobiology       Date:  2020-11-24       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.